Table 1 Top 30 multi-cancer CpG-exon correlations across all the cancer types
CpG | Exon | Gene | Cancer | Correlation | Majority sign |
|---|---|---|---|---|---|
cg23538703 | chr3:118864997-118866434:+ | RP11-484M3.5 | breast; cervical | 0.845 | − |
cg02425416 | chr11:2170356-2170833:- | INS-IGF2 | cholangiocarcinoma; liver | 0.822 | \(+\) |
cg02425416 | chr11:2170356-2170575:- | INS-IGF2 | cholangiocarcinoma; liver | 0.821 | \(+\) |
cg02425416 | chr11:2168796-2169037:- | INS-IGF2 | cholangiocarcinoma; liver | 0.818 | \(+\) |
cg05777976 | chr11:2170356-2170833:- | INS-IGF2 | cholangiocarcinoma; liver | 0.807 | \(+\) |
cg05777976 | chr11:2170356-2170575:- | INS-IGF2 | cholangiocarcinoma; liver | 0.803 | \(+\) |
cg05777976 | chr11:2168796-2169037:- | INS-IGF2 | cholangiocarcinoma; liver | 0.802 | \(+\) |
cg13167664 | chr11:2170356-2170575:- | IGF2 | cholangiocarcinoma; liver | 0.792 | \(+\) |
cg04083712 | chr7:99158156-99158318:+ | GS1-259H13.10 | colon; esophageal | 0.786 | − |
cg13167664 | chr11:2170356-2170833:- | IGF2 | cholangiocarcinoma; liver | 0.782 | \(+\) |
cg01814130 | chr3:118906622-118906822:+ | RP11-484M3.5 | bladder; cervical | 0.773 | − |
cg14458615 | chr3:118864997-118866434:+ | RP11-484M3.5 | breast; cervical | 0.766 | − |
cg12389423 | chr3:118864997-118866434:+ | RP11-484M3.5 | breast; cervical | 0.765 | − |
cg10066151 | chr19:57874879-57875071:+ | AC003002.4 | cervical; brain | 0.756 | − |
cg15744005 | chr10:104632854-104632990:+ | C10orf32-ASMT | breast; cervical | 0.755 | − |
cg20675391 | chr3:118864997-118866434:+ | RP11-484M3.5 | breast; cervical | 0.751 | − |
cg15744005 | chr10:104632205-104632355:+ | C10orf32-ASMT | breast; cervical | 0.750 | − |
cg27331871 | chr11:2168796-2169037:- | INS-IGF2 | cholangiocarcinoma; liver | 0.749 | \(+\) |
cg05777976 | chr11:2170356-2170833:- | IGF2 | cholangiocarcinoma; liver | 0.747 | \(+\) |
cg05777976 | chr11:2170356-2170575:- | IGF2 | cholangiocarcinoma; liver | 0.746 | \(+\) |
cg02166532 | chr11:2170356-2170575:- | IGF2 | cholangiocarcinoma; liver | 0.744 | \(+\) |
cg15744005 | chr10:104629841-104629968:+ | C10orf32-ASMT | breast; cervical | 0.744 | − |
cg04334121 | chr11:18257383-18257477:- | SAA4 | cholangiocarcinoma; liver | 0.743 | − |
cg16817891 | chr11:2170356-2170575:- | INS-IGF2 | cholangiocarcinoma; liver | 0.743 | \(+\) |
cg04334121 | chr11:18253942-18254080:- | SAA4 | cholangiocarcinoma; liver | 0.742 | − |
cg13167664 | chr11:2168796-2169037:- | IGF2 | cholangiocarcinoma; liver | 0.741 | \(+\) |
cg16817891 | chr11:2170356-2170833:- | INS-IGF2 | cholangiocarcinoma; liver | 0.740 | \(+\) |
cg27331871 | chr11:2170356-2170833:- | INS-IGF2 | cholangiocarcinoma; liver | 0.740 | \(+\) |
cg20844262 | chr20:62365997-62366176:+ | ZGPAT | cholangiocarcinoma; liver | 0.740 | − |